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Summary
Objective: Since ﬁbronectin fragments (Fn-fs) enhance cartilage damage through integrins, the objective was to investigate the role of integrin
linked kinases, focal adhesion kinase (FAK) and a soluble form of FAK, proline rich tyrosine kinase 2 (Pyk2) and cellular src kinase (c-src) and
the transcription factor, nuclear factor kB (NF-kB) in cartilage damage.
Methods: Bovine chondrocytes were cultured with various concentrations of three different Fn-fs, an amino-terminal 29 kDa, a gelatin binding
50 kDa and a central 140-kDa Fn-fs, each with progressively weaker cartilage damaging activity, or with native ﬁbronectin (Fn), and lysates
probed for activation of the selected kinases. Confocal microscopy was used to visualize intracellular location of activated kinases and NF-kB.
Various kinase inhibitors were tested for their effects on Fn-f mediated upregulation of matrix metalloproteinase (MMP)-3 and -13 and cartilage
proteoglycan (PG) depletion.
Results: The Fn-fs kinetically enhanced phosphorylation of FAK but did not show a clear doseeresponse effect. The 29-kDa and 50-kDa Fn-fs
enhanced phosphorylation of Pyk2, c-src and NF-kB to a much greater extent than the 140-kDa Fn-f and native Fn and did so as a function of
dose. The 29-kDa Fn-f enhanced the phosphorylation of nuclear Pyk2 as compared with no treatment or native Fn. Inhibitors of Pyk2, c-src,
NF-kB and protein kinase Cd (PKCd) decreased MMP upregulation and decreased Fn-f mediated damage to cartilage.
Conclusions: These studies enhance our knowledge of crucial factors in Fn-f mediated signaling in MMP upregulation and cartilage damage
and because of the potential physiologic relevance of Fn-fs, provide a better knowledge of cartilage degeneration in general.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Abbreviations: Fn-f ﬁbronectin fragment, Fn ﬁbronectin, MMPs matrix metalloproteinases, FAK focal adhesion kinase, Pyk2 proline rich tyro-
sine kinase 2, NF-kB nuclear factor kB, PG proteoglycan, PI3K phosphoinositide 3-kinase, PKCd protein kinase Cd isoform, iNOS inducible
nitric oxide synthase, MAP mitogen activated protein, MMP-13 matrix metalloproteinase-13, collagenase 3, ECL enhanced chemiluminescent,
HRP horse radish peroxidase, TRITC tetramethyl rhodamine iso-thiocyanate, IgG immunoglobulin G, DAPI 40-6-Diamidino-2-phenylindole,
MMP-3D MMP-3 digest of Fn, EGTA ethylene glycol tetraacetic acid, PMSF phenylmethyl sulfonyl ﬂuoride, DTT dithiothreitol, TBS 20 mM
Tris buffer, pH 7.4, containing 140 mM NaCl, BSA bovine serum albumin, PBS phosphate buffered saline, TBST Tris buffered saline-Tween
20, SD standard deviation, DMSO dimethylsulfoxide, Grb2 growth factor receptor-bound protein 2, BAPTA/AM 1,2-bis(o-aminophenoxy)-
ethane-N,N,N 0,N 0-tetraaceticacid tetra(acetoxymethyl) ester.Introduction
Proteolytic cleavage of ﬁbronectin (Fn) which occurs in carti-
lage degeneration creates ﬁbronectin fragments (Fn-fs) that
have cartilage chondrolytic activities1 through their abilities to
elevate matrix metalloproteinase (MMP) expression2e4,
suppress proteoglycan (PG) synthesis in cartilage5e7,
enhance rates of PG loss from cartilage tissue in explant
cultures1e3,5e7 and upregulate catabolic cytokines8,9. Fn-fs
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1385a5b1 integrin receptor, since analog peptides of integrin-
binding sequences of native Fn block activities of the Fn-fs10,
Fn-fs can be chemically crosslinked to the a5 subunit
11 and
reduction of a5b1 levels by antisense oligonucleotides re-
duces Fn-f activities12. The Fn-fs enhance expression of
a number of MMPs2e4 and enhance aggrecanase like cleav-
age13. Fn-fs also upregulate inducible nitric oxide synthase
(iNOS)14 and nitric oxide (NO) levels15 as well as the toll-
like receptor 216. The combined effects of these actions on
catabolic pathways are severe. Fn-fs at or below concentra-
tions found in osteoarthritis (OA) synovial ﬂuid, 0.1e1 mM,
when added to cultures of cartilage explants, cause degra-
dation and irreversible release of up to half of the matrix
PG within days6,7. The relevance of these effects of the
Fn-fs is supported by observations that injection of Fn-fs
into normal rabbit knee joints causes a severe loss of artic-
ular cartilage PG17,18. Major aspects of this model have
been reviewed19.
1386 L. Ding et al.: Fibronectin fragments enhance Pyk2, NF-kBThere are only a few studies on Fn-f signal transduction
pathways that relate to catabolic pathways in chondro-
cytes. It has been shown that focal adhesion kinase
(FAK) and mitogen activated protein (MAP) kinases medi-
ate NO production by a 29-kDa amino-terminal Fn-f added
to human knee cartilage chondrocytes15. Further, MAP ki-
nase and protein kinase C (PKC) dependent activation of
proline rich tyrosine kinase 2 (Pyk2) were implicated in
matrix metalloproteinase-13 (MMP-13) upregulation by
a 110-kDa Fn-f added to human chondrocytes20,21. In our
ongoing work, we have conﬁrmed in detail the kinetics
and dose dependencies of MAP kinase activation in Fn-f
mediated MMP-3 and -13 upregulation and cartilage dam-
age in a bovine chondrocyte and explant culture model and
shown that three different Fn-fs, each with differing ability
to enhance cartilage matrix damage, showed differential ef-
fects on activation of MAP kinases22. In this work we have
extended our analysis to other kinases, including FAK,
Pyk2, protein kinase Cd (PKCd), cellular src kinase (c-
src) and nuclear factor kB (NF-kB), to determine whether
all three Fn-fs utilize the same players both in enhancing
MMPs and in causing cartilage damage.Experimental proceduresMATERIALSThe LIVE/DEAD Reduced biohazard Viablity/Cytotoxic-
ity Kit #1 (L-7013) was purchased from Invitrogen
(Eugene, OR; Carlsbad, CA). Antibodies to b-actin, total
and phospho-FAK (Tyr576), total and phospho-Pyk2
(Tyr402), total and phospho-src family (Tyr416), total and
phospho p65 NF-kB (Ser536) antibodies and horse radish
peroxidase (HRP)-conjugated goat anti-rabbit immunoglob-
ulin G (IgG) were purchased from Cell Signaling Technol-
ogy (Danvers, MA). The secondary antibody for MMP
detection, HRP-linked goat anti-rabbit IgG, was from Sigma
Chem. Co. (St. Louis, MO). Polyclonal antibodies to human
MMP-3 and -13 were from Chemicon International Inc. (Te-
mecula, CA). All kinase inhibitors and the protease Inhibitor
cocktail II reagent were from CalBiochem (San Diego, CA).ISOLATION OF Fn-fsA well-characterized amino-terminal heparin-binding 29-
kDa Fn-f and a gelatin-binding 50-kDa Fn-f were isolated
by sequential cathepsin D and thrombin digests of human
plasma Fn as described1. A mixture of non-gelatin binding
C-terminal Fn-containing the cell-binding 70 to 140-kDa
Fn-fs as well as smaller C-terminal Fn-fs, referred to as
the 140-kDa Fn-f were also studied. The 29-kDa Fn-f has
been identiﬁed in extracts from OA cartilage23 and in
MMP-3 generated digests of Fn24.KINASE ACTIVATION STUDIESChondrocyte cultures were established and cells treated
with 0.5 mM Fn or Fn-fs for various times and lysed at 0,
15 min, 1 h, 4 h and 12 h in cold lysis buffer as described22.
To study doseeresponse effects, cultures were adjusted to
10 nM to 1 mM Fn or Fn-f and cell lysates recovered at 1 h.
At the end of experiments and after up to 24 h, wells
treated in parallel were tested for cell viability using a viabil-
ity/cytotoxicity kit from Invitrogen (Carlsbad, CA). Several
ﬁelds of over 3000 cells per ﬁeld were visualized using
an Olympus D-71 ﬂuorescent microscope. Western blottingand chemiluminescent detection for kinases and MMPs
were as described22. Probing for total kinase served as
a loading control as well as probing, in some cases, for
b-actin.CONFOCAL MICROSCOPY PROBING FOR KINASESTo visualize intracellular location of kinases, cells were
ﬁrst ﬁxed and after being blocked by 5% donkey serum
diluted in 0.5% bovine serum albumin (BSA) in phos-
phate buffered saline (PBS), probed with antibodies to
phosphorylated kinases using dilutions of 1:75, followed
by reaction with tetramethyl rhodamine iso-thiocyanate
(TRITC) conjugated AfﬁniPure donkey anti-rabbit IgG
(Hþ L) using dilutions of 1:200. After washing, cells
were incubated in 300 nM 40-6-diamidino-2-phenylindole
(DAPI) solution for 3e5 min at room temperature and
rinsed with PBS 2e3 times before mounting with VECTA-
SHIELD Mounting Medium (Vector Laboratories, Burlin-
game, CA).TESTS OF KINASE INHIBITORS ON MMP UPREGULATION BY
THE 29-KDa Fn-f AND ON Fn-f MEDIATED PG DEPLETIONTo test effects of inhibitors on MMPs, monolayer cultures
were incubated with inhibitors over a 100-fold concentration
range including concentrations reported by others to be
maximally effective20e22. Inhibitors were typically dissolved
in dimethylsulfoxide (DMSO) such that the ﬁnal concentra-
tion in culture media would be 0.4% and to control for ef-
fects of DMSO, a DMSO alone control was run. At the
end of experiments, wells treated in parallel were tested
for cell viability. To test effects on PG depletion, cartilage sli-
ces from bovine metacarpophalangeal joints were cultured
as described in 10% serum/DMEM5e8 and were preincu-
bated with kinase inhibitors for 24 h, then adjusted to
1 mM 29-kDa Fn-f and PG content assayed at 7 d as de-
scribed2. The ﬁnal mean and standard deviation (SD)
values were calculated and control vs experimental data
were compared using two-tailed unpaired Student’s t tests.
A P value <0.05 was considered signiﬁcant.ResultsFn-fs HAD ONLY WEAK EFFECTS ON ACTIVATION OF FAKInitial control experiments showed that untreated cells or
cultures adjusted to 0.5 mM BSA as a protein control did not
show signiﬁcant activation (data not shown). The experi-
ments were performed with three different chondrocyte
preparations with similar results and representative blots
are shown. The different primary cultures led to some vari-
ability, especially in untreated controls and exposure times
of blots were varied to allow for visualization of more fea-
tures which also allowed for apparent variability of controls.
Nonetheless, each chondrocyte preparation gave internally
consistent data. Figure 1(A) shows that there were only
weak kinetic effects by Fn-fs and Fn on activation of FAK.
Note that the loading control strips for total kinase, labeled
t, show even loading. The p strips correspond to phosphor-
ylation strips. We next examined the doseeresponse rela-
tionship at a 1 h time point, since other preliminary studies
had shown a maximal effect of the 29-kDa Fn-f on p38
MAP kinase at that time point. Figure 1(B) shows that the
three Fn-fs and Fn, from 0.01 to 1 mM, did not enhance
phosphorylation at 1 h.
Fig. 1. Effect of Fn and Fn-fs on kinetics (A) and dose dependency
(B) of phosphorylation of Tyr576 of FAK. Chondrocyte cultures
were established in 6 well culture dishes in 10% FBS/DMEM for
4e5 d and then serum starved by media change to DMEM for
24 h. Media were changed to fresh DMEM 2 h prior to treatment
with Fn-fs or Fn. Panel A: cells were treated with 0.5 mM of each
Fn-f or Fn and lysed at 0 h, 0.25 h, 1.0 h, 4.0 h and 12.0 h. Aliquots
(5 mg protein) were subjected to electrophoresis on 10% acrylami-
deeSDS gels and blotted with antibodies to phosphorylated
Tyr576 of FAK (p strips) or to total FAK (t strips). Panel B: cells
were treated with the Fn-fs or Fn at concentrations ranging from
0.01 to 1.0 mM and cell lysates were recovered at 1 h.
Fig. 2. Effect of Fn and Fn-fs on kinetics (A) and dose dependency
(B) of phosphorylation of Tyr402 of Pyk2. Similar conditions to
Fig. 1, except the antibody used was against phosphorylated
Tyr402 (p strips) of Pyk2 and b-actin was used as a loading control
(b strips).
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PHOSPHORYLATION OF Pyk2Similar analysis was applied to Pyk2. As shown in
Fig. 2(A), the three Fn-fs at 0.5 mM, but not native Fn, en-
hanced phosphorylation of Pyk2 from 15 min up to at least
12 h. Since the antibody to total Pyk2 was unstable with
storage, b-actin was used as a loading control, as shown
in the b strips. The antibody used for phosphorylation was
directed toward Tyr402, an autophosphorylation site25.Fig. 3. Effect of Fn and Fn-fs on kinetics (A) and dose dependency (B)
antibodies were against total phosphorylated TThe effects of the 140-kDa Fn-f appeared to be less than
that of the other two Fn-fs and native Fn decreased phos-
phorylation with time. Figure 2(B) shows the doseeres-
ponse effects at 1 h. Each Fn-f displayed a concentration
dependent effect, with maximal effects above 0.1 mM. The
140-kDa Fn-f and native Fn patterns appeared to be weaker
and had a similar proﬁle with a bell shaped response be-
tween 0.01 mM and 0.3 mM.Fn-fs ENHANCED PHOSPHORYLATION OF c-srcc-src can be phosphorylated at Y416 to increase its activ-
ity26. Figure 3(A) shows that the 29-kDa Fn-f kineticallyof phosphorylation of Tyr 416 of c-src. Similar to Fig. 1 except the
yr 416 of c-src (p strips) or total (t strips).
Fig. 4. Effect of Fn and Fn-fs on kinetics (A) and dose dependency
(B) of phosphorylation of Ser536 of p65 NF-kB. Similar to Fig. 1 ex-
cept the antibodies were against phosphorylated NF-kB (p strips) or
total NF-kB (t strips).
1388 L. Ding et al.: Fibronectin fragments enhance Pyk2, NF-kBenhanced phosphorylation of 60-kDa c-src by 12 h. MW po-
sitions are shown to the right in the upper left gel. All three
Fn-fs and Fn enhanced phosphorylation of smaller 45-kDa
and 40-kDa forms within 15 min to 1 h. Figure 3(B) shows
doseeresponse effects at 1 h; the 29-kDa Fn-f was effectiveFig. 5. Effect of 29-kDa Fn-f and Fn on intracellular distribution of phosph
10% serum for 4e5 d in 8 well chamber slides and then serum deprived
ﬁxed and analyzed for distribution of p-Pyk2, p-c-src and p-FAK by ﬂuore
visualize the nucleus. Control cells were untreated. Cont Enl-untreated and
enhance visuaon both 60-kDa c-src and the smaller forms at 0.01 mM and
above. The 50-kDa Fn-f at 1 mM, higher than the 0.5 mM
concentration studied in panel A, showed slight activity to-
ward the 60-kDa form but had a greater effect on the 45-
kDa and 40-kDa forms. The 140-kDa Fn-f at 0.01 mM and
above enhanced phosphorylation of the 40-kDa form. While
there were some differences in absolute effects between
the kinetic and doseeresponse data, perhaps due to a cul-
ture to culture variation, all three Fn-fs and Fn appeared to
enhance activation of smaller c-src forms.Fn-fs ALSO ENHANCED ACTIVATION OF NF-kBFigure 4(A) shows that all three Fn-fs enhanced phos-
phorylation of NF-kB within 15 min for up to 12 h while Fn
was ineffective. Doseeresponse data in Fig. 4(B) show ef-
fects by 1 h with concentrations as low as 0.1 mM for all
three Fn-fs and that native Fn decreased phosphorylation.CONFOCAL FLUORESCENT MICROSCOPY CONFIRMED
ACTIVATION OF Pyk2Cells were treated with the 29-kDa Fn-f or Fn for 4 h, ﬁxed
and then reacted with the nuclear staining dye DAPI as well
as antibodies to phosphorylated kinases. Figure 5, column
A, shows in untreated cells very little red TRITC signal
that would indicate phosphorylated Pyk2, FAK or c-src.
The untreated cells also show a clear nuclear blue pattern
for the nucleus. However, with Fn-f treatment (column B)
there is a red tint in the otherwise blue nucleus and the for-
mation of red bodies within the nucleus in the anti-phospho-
Pyk2 treated cells. Some red staining of the cell membrane
of Fn-f treated cells is obvious. For phospho-FAK, there was
very little difference in the distribution of FAK inside cells be-
tween Fn-f treated and untreated cells. For phospho-c-src,orylated FAK, Pyk2 and c-src. Cells were incubated in DMEM with
for 24 h. The 29-kDa Fn-f or Fn was added and after 4 h cells were
scent confocal microscopy. Cells were counterstained with DAPI to
Enl-Fn-f treated were arbitrarily chosen ﬁelds that were enlarged to
lization.
1389Osteoarthritis and Cartilage Vol. 17, No. 10the Fn-f enhanced the amount of phospho-c-src compared
to untreated control cells, but the extent was less than the
effects of Fn-f on phospho-Pyk2. With native Fn treatment
(column C), the patterns were more similar to that of un-
treated controls in that there was little colocalization of
DAPI and kinases. The inserts in columns D and E are of
enlarged images of the central regions of columns A and
B and more clearly suggest that the phosphorylated forms
of all three kinases showed very little perinuclear distribu-
tion in untreated cells, but show very clear colocalization
with DAPI in Fn-f treated cells. Also note in Fn-f treated
cells, there is a suggestion of intranuclear bodies containing
activated kinases.Fn-f MEDIATED MMP UPREGULATION WAS BLOCKED BY
TYROSINE KINASE, Pyk2, c-src, NF-kB AND PKC INHIBITORS
AND CALCIUM BLOCKERSIn order to link increased phosphorylation of the kinases
with MMP upregulation, cells were cultured with various ki-
nase inhibitors for 2 h, the media then adjusted to 1 mM 29-
kDa Fn-f and media probed for MMP-3 and MMP-13 after
24 h. A 100-fold concentration range of inhibitor was stud-
ied, a range that included as the highest, the concentrations
reported by others to be effective in other systems15,21. AsFig. 6. Effect of kinase inhibitors on 29-kDa Fn-f mediated MMP-3
and MMP-13 upregulation. Bovine chondrocyte cultures in 24 well
plates were ﬁrst serum starved for 24 h, and then adjusted to vari-
ous concentrations of inhibitor. After 2 h, media were adjusted to
1 mM 29-kDa Fn-f and after 24 h, media removed, dialyzed against
water, concentrated 10, samples reduced with 0.05 M dithiothrei-
tol (DTT) and subjected to electrophoresis on 10% acrylamide gels.
Gels were blotted onto nitrocellulose and blots treated with anti-
MMP-3 or -13, followed by detection of bands by chemilumines-
cence. D refers to a DMSO control (0.4%) and f to Fn-f treatment
in the presence of DMSO. The third lane is inhibitor/DMSO by itself
and the rest of the lanes are increasing concentrations of inhibitor
with Fn-f/DMSO.shown in Fig. 6, the DMSO carrier by itself (D lane) had no
or only weakly detectable effects on MMP expression as
compared with Fn-f treatment, while the Fn-f with DMSO
carrier (f) greatly enhanced MMP-3 and -13. The third
lane in each panel shows that the inhibitors are by them-
selves in DMSO at the highest concentrations and that
there was no signiﬁcant effect on MMP expression. The up-
per panel in the top most set shows that a general tyrosine
kinase inhibitor, AG82, very signiﬁcantly decreased MMP-3
when used at a concentration of 1 mM and above while
10 mM was required for effects on MMP-13. In the next
lower sets, two speciﬁc inhibitors of the FAK/phosphoinosi-
tide 3-kinase (PI3K) pathway were tested. Wortmannin was
ineffective but LY294002 had an effect at 10 mM. The Pyk2
panels show that speciﬁc inhibitor of Pyk2, AG17, almost
completely abolished Fn-f induced MMP upregulation at
a concentration as low as 1 mM. The last two sets of panels
for c-src show that the src inhibitor II more markedly de-
creased both MMPs than did PP2. In the srcII inhibitor ex-
periment, untreated DMSO controls did show elevated
MMP expression but Fn-f still enhanced levels even further.
Figure 7 shows the results of other inhibitors. The NF-kB
inhibitor, BAY-117082, had complete inhibitory effects at
10 mM and above on both MMPs. Since Pyk2 is regulated
by calcium27, we investigated the effects of calcium block-
ing on MMP upregulation. As shown in Fig. 7, Nifedipine
did not have an obvious blocking effect on MMP-3,
nor MMP-13. However, 1,2-bis(o-aminophenoxy)ethane-
N,N,N 0,N 0-tetraaceticacid tetra(acetoxymethyl) ester
(BAPTA/AM), another calcium blocker, was very effective
toward MMP-3. MMP-13 was not tested. Two PKC inhibi-
tors were also tested, bisindoylmaleimide (BIM) as a general
inhibitor for the PKC family and rottlerin as a speciﬁc inhib-
itor of PKCd. Both inhibitors decreased Fn-f mediated MMP
upregulation, while rottlerin was more potent than BIM. Both
inhibitors were effective at 10 mM in blocking MMP-3, while
effects of rottlerin on MMP-3 occurred even lower, at 1 mM.
Effects on MMP-13 were not tested. In viability tests, we
found that only a few cells in ﬁelds of over 3000 cells
each were found to be dead in any of the inhibitor experi-
ments. This was not greater than in untreated cultures.Fig. 7. Effect of NF-kB inhibitor, calcium inhibitors and PKC inhibi-
tors on 29-kDa Fn-f mediated MMP-3 and MMP-13 upregulation.
Conditions were similar to Fig. 6.
1390 L. Ding et al.: Fibronectin fragments enhance Pyk2, NF-kBThese experiments were performed with three different
chondrocyte preparations with similar results.THE Pyk2, c-src, NF-kB AND PKCd INHIBITORS ALSO
DECREASED Fn-f MEDIATED CARTILAGE PG DEPLETIONIn order to test the active roles of the kinases in causing
cartilage damage, explants were cultured in the presence of
selected inhibitors at the highest respective concentrations
tested earlier for 24 h, prior to addition of 1 mM 29-kDa Fn-f.
After 7 d, the PG content of cultured cartilage was mea-
sured. As shown in Fig. 8, addition of DMSO as the inhibitor
carrier (D) did not change PG content as compared with un-
treated control (C). However, Fn-f alone (f) and the Fn-f with
DMSO treatment (Dþ f) caused signiﬁcant damage. Signif-
icance was determined by comparison with the DMSO con-
trol (D). Treatment with the Pyk2 inhibitor, AG17, or the
c-src inhibitor II (SrcII) or the PKCd inhibitor rottlerin or the
NF-kB inhibitor Bay-117082 alone did not alter PG content
as compared to control while the FAK/PI3K inhibitor,
LY294002, by itself did signiﬁcantly decrease PG content.
However, when inhibitors were added with Fn-f, treatment
with AG17 signiﬁcantly enhanced PG content to signiﬁ-
cantly higher levels than the D control while SrcII or rottlerin
reduced Fn-f mediated damage to D control levels.
LY294002 did not decrease the effects of the Fn-f while
the Bay compound and Fn-f combination increased PG
content over untreated control. When the inhibitor plus Fn-
f data were compared to the Dþ f control, the LY data
were signiﬁcantly greater than the Dþ f data (P< 0.05),
while the LYþ f were not signiﬁcantly different. However,
all of the other comparisons showed that the inhibitors sig-
niﬁcantly decreased the activity of Fn-f and DMSO combi-
nations at the level of P< 0.01.Fig. 8. Effect of inhibitors on Fn-f mediated cartilage matrix PG de-
pletion in 10% serum 7 d cultures. Bovine cartilage was cultured in
DMEM without serum for 1e2 d, then media were changed to
DMEM with 10% serum. Inhibitors were added 24 h before Fn-f
treatment. Media and reagents were renewed every other day. Af-
ter 7 d in 10% serum/DMEM, cartilage was recovered, weighed,
subjected to papain digestion and PG content was measured with
DMB reagent. Bars are SD values. *P < 0.05, **P < 0.01,
***P< 0.001 compared to DMSO control. Bars are C for untreated
control, D for DMSO control; Dþ f for DMSO and Fn-f combination;
f for Fn-f alone with no DMSO; AG17 for 10 mM AG17; AG17þ f for
combination; LY for 100 mM LY294002 and LYþ f for combination;
SrcII for 20 mM c-src inhibitor II and SrclIþ f for combination, rot for
10 mM rottlerin and rotþ f for combination; Bay for 100 mM Bay-
117082 and Bayþ f for combination.Discussion
This work extends earlier observations of the role of Pyk2
and NF-kB in a different study system in which the effects of
1 mM concentrations of a 110-kDa Fn-f on human articular
chondrocytes and immortalized human cell lines were stud-
ied21,28 or in which the effect of a carboxyl-terminal Fn-f on
NF-kB activation in rheumatoid chondrocytes was stud-
ied29. Other work has shown that a 110-kDa Fn-f activated
Pyk2 in a time course, that the activity was inhibited by
chemical inhibitors, that overexpression of adenoviral
Pyk2 enhanced MMP-13 production and that the 110-kDa
Fn-f enhanced Pyk2 activation was upstream of PKCd21.
Our work here shows for the ﬁrst time the involvement of
c-src in Fn-f mediated MMP upregulation and cartilage
damage and also shows the involvement of Pyk2, NF-kB
and PKCd in a bovine cartilage Fn-f mediated cartilage
damage model, conﬁrming earlier work on human cells21,28.
In this work we have not only included three different
types of Fn-fs but also compared to native Fn, which is rel-
atively inactive in causing cartilage damage1. We have uti-
lized an Fn-f/bovine model because of the considerable
characterization of this model19 and its usefulness in relat-
ing signaling to cartilage damage. This work could have
been strengthened by using approaches additional to
chemical inhibitors such as testing effects of dominant neg-
ative constructs. Chemical inhibitors have the potential to
lose speciﬁcity as concentrations are increased and toxicity
is always a concern. Further, the nonspeciﬁc targets of all
inhibitors are not always adequately studied30. However,
our use of common inhibitors and doseeresponse curves
which included suboptimal concentrations and toxicity con-
trols rendered conﬁdence in our conclusions.
Three different Fn-fs were studied to determine if their dif-
ference in potencies in terms of causing cartilage damage
might relate to differences in activation of kinases. The
29-kDa Fn-f is the most potent Fn-f in terms of cartilage
damage, followed by the 50-kDa and ﬁnally the 140-kDa
Fn-f1. These Fn-fs can be found in pathologic states. We
have detected 30-kDa and 140-kDa Fn-fs in OA synovial
ﬂuids31, shown that addition of IL-1 to cultured bovine ex-
plants generates 30-120-kDa Fn-f, that addition of MMP-3
to synovial ﬂuid generates 30e100 kDa Fn-f and we have
shown the 30-kDa N-terminal Fn-fs in extracts of OA carti-
lage24. Further, we have shown an amino-terminal 29-kDa
like Fn-f in MMP-3 digests of native Fn23. Thus, several dif-
ferent types of Fn-fs can be generated and their masses in-
clude the 29-kDa, 50-kDa and 140-kDa Fn-f studied here,
which in turn are dominant forms.
An important conclusion from these studies is that these
three different Fn-fs all utilize a common pathway. This is
particularly interesting because these Fn-fs differ in interac-
tions with the matrix and the alpha5beta1 Fn receptor. Only
the 140-kDa Fn-f is known to bind directly to the integrins on
the cell surface and also binds heparin sulfate PG32. While
we have shown that the 29-kDa and 50-kDa Fn-fs can bind
to immobilized and higher puriﬁed alpha5beta1
11, we have
never demonstrated this interaction on the cell surface.
However, since we have shown that all three Fn-f can be
chemically crosslinked to the alpha5 subunit on the chon-
drocyte cell surface does the Fn-fs all bind proximal to the
receptor. The 29-kDa Fn-f likely binds the matrix perhaps
through interaction with sulfated glycosylaminoglycans
and the 50-kDa Fn-f, which contains a gelatin-binding do-
main, might bind collagen, in binding modes that allow the
Fn-fs to be physically close to the alpha5 subunit. We
have proposed that these interactions with matrix might
1391Osteoarthritis and Cartilage Vol. 17, No. 10perturb integrin interaction with native Fn19 or the Fn-fs
might bind to native Fn in a polymerization mode33 to alter
interaction of Fn ﬁbrils with integrins.
The most upstream integrin pathway players tested were
FAK, Pyk2 and c-src. Our comparison between the Fn-fs
and with Fn suggested that the most potent Fn-f, the 29-
kDa Fn-f had greater or faster effects on Pyk2 and c-src.
Thus, these two kinases should be considered major targets
for further studies. In terms of FAK, the data did not suggest
a clear effect on activationwhile tests with an FAK/PI3 kinase
inhibitor suggested that FAK or PI3K was involved in MMP
upregulation and cartilage damage. However, the inhibitor it-
self caused cartilage damage. Because this inhibitor blocks
the PI3 kinase arm of the complex FAK signaling network,
it may have affected MMP expression less directly than the
other inhibitors or had secondary effects and thus, the data
should not be used to imply involvement of FAK. We con-
clude that our data do not support a role for FAK in the path-
way, certainly as compared with Pyk2.
However, the 29-kDa and 50-kDa Fn-fs, which are the
most potent in enhancing MMPs and causing cartilage dam-
age and that likely do not bind directly to integrin receptors,
had obvious effects on activating Pyk2, while the 140-kDa
Fn-f and Fn had weaker effects. Tests of kinase inhibitors
suggested that Pyk2 has an active role in MMP-3 upregula-
tion and Fn-f mediated cartilage damage. Confocal analysis
conﬁrmed that Pyk2 was more activated than FAK and
c-src. Studies with DAPI were consistent with the Fn-f
enhancing the amount of activated Pyk2, however the inten-
sity of the red staining made interpretation of nuclear loca-
tion difﬁcult. We will continue to investigate the possibility
of movement of Pyk2 since there is one report that cyclic
strain of osteoblast like cells causes early movement of
Pyk2 from focal contacts to the cytoskeleton while FAK re-
mains34, consistent with the possibility that the movement of
Pyk2 allows Fn-f activity. The utilization by Fn-fs of Pyk2
rather than FAK can be discussed in relationship to obser-
vations that Pyk2 and FAK, despite having structural simi-
larities, cause different signaling pathways35,36 but both
can be involved in MAP kinase activation27,37e39. However,
there may be a reciprocal relationship. For example, induc-
tion of Pyk2 inhibits G1 to S phase transition while FAK ex-
pression accelerates40.
The involvement of c-src was difﬁcult to interpret since
the activation of classical 60-kDa form was mostly found
in the 29-kDa Fn-f treated cultures, while the other two
Fn-fs had greater effects on smaller 40-kDa and 45-kDa
forms. We do not know if these lower mass forms are deg-
radation products or cross-reacting forms of the c-src fam-
ily, such as c-src, transforming gene of Yamaguchi 73 and
Esh avian sarcoma viruses (Yes), yes-related kinase
(Yrk), Gardner-Rasheed feline sarcoma viral oncogene
homolog (Fgr), fyn oncogene related to src (Fyn), leuko-
cyte-speciﬁc protein kinase (Lck), V-yes-1 Yamaguchi
sarcoma viral related oncogene homolog (Lyn), hemopoi-
etic cell kinase (Hck), and B lymphoid tyrosine kinase
(Blk)41. However, tests with the c-src inhibitors did conﬁrm
an active role for c-src in MMP upregulation as well as Fn-
f mediated cartilage damage and this is the ﬁrst report of
such as a role. Since c-src translocates from the plasma
membrane to the cytosol upon activation42, we will ex-
plore this possibility in more detail. The involvement of
c-src in the Fn-f pathway would be consistent with
a role in Pyk2 activation since c-src family kinase activity
has been shown to regulate Pyk2 phosphorylation, al-
though in one study c-src was shown to inactivate Pyk2
in FAK deﬁcient cells43.However, other work has conﬁrmed that Pyk2 tyrosine
phosphorylation is dependent upon activity of other c-src
family members44,45 and that c-src and Pyk2 interaction
can lead to MAP kinase activation46. However, interaction
between these two players is complex. c-src has been
shown, in turn, to be a substrate of Pyk2 and through this
activation, activate a JNK pathway46. In fact, association
between Pyk2 and c-src has been shown to activate extra-
cellular signal-related kinase 1, 2 (ERK1/2)47. Interestingly,
c-src has been shown to bind to and activate NF-kB in
a non-MAP kinase pathway47e49.
The activation of NF-kB and the effects of its inhibitor in
decreasing MMP upregulation and cartilage damage clearly
demonstrated its crucial role in the cartilage damage path-
way. At present we do not know if NF-kB is a substrate of
c-src in this pathway as suggested above, but we do
know that inhibition of MAP kinases does not inhibit NF-
kB phosphorylation (unpublished), suggesting two separate
pathways. As discussed above, c-src can activate NF-kB in
a non-MAP kinase pathway. Our preliminary observations
also suggest that Pyk2 is upstream of NF-kB in that inhibi-
tion of Pyk2 decreases NF-kB activation.
Since Pyk2 would be affected by calcium levels and its
activity should be linked to calcium activated PKC forms27,
we tested effects of calcium blockers on MMP upregulation
and found that BAPTA/AM, but not Nifedipine, decreased
MMP-3 upregulation. Further, inhibition of PKC, especially
PKCd, markedly decreased 29-kDa Fn-f mediated MMP up-
regulation, similar to effects on a 110-kDa Fn-f added to hu-
man chondrocytes21. Since calcium regulated PKC
pathways might activate Pyk2 and c-src, the mechanism
by which PKCd can will be a future focus. A possible model
pathway might be that calcium activates PKCd, followed by
Pyk2 as shown for the 110-kDa Fn-f21 and this might lead to
c-src and NF-kB activation and MMP upregulation. A sepa-
rate arm might involve MAP kinase activation that directly
leads to MMP upregulation. Regardless of the pathway(s),
inhibition of these kinases may have therapeutic potential.Conﬂict of interest
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